VIDAS SARS-CoV-2 IgM Diagnostic Test Recalled for Substrate Error
bioMerieux is recalling one lot of VIDAS SARS-CoV-2 IgM tests nationwide due to a substrate defect that prevents the test from running. The defect causes delayed results as users must repeat testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II medical device recall with no reported illnesses, hospitalizations, or injuries. The hazard is operational—a substrate defect that prevents test execution—rather than a direct patient safety threat. The precautionary and operational nature of this recall aligns with Score 2 (Moderate) per the rubric.
Plain-English summary
bioMerieux, Inc. is recalling one lot (Lot #1008710950) of VIDAS SARS-CoV-2 IgM diagnostic tests distributed nationwide. The recall involves UDI 03573026620738 for product Ref 423833-01.
The recall is prompted by an increasing number of complaints related to a substrate error in this lot. The defect prevents the test from being run, making it impossible to complete the diagnostic procedure. Users experiencing this error must run another test to obtain results, causing potential delays in patient diagnosis.
Healthcare providers and laboratory facilities using this lot should discontinue testing with affected units and contact bioMerieux, Inc. for replacement tests and further guidance.
The recalled product
- Product
- VIDAS SARS-COV-2 IgM, Ref 423833-01
- Manufacturer
- bioMerieux, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- UDI 03573026620738
- Lot #: 1008710950
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by bioMerieux, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · bioMerieux, Inc.
See all →- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- HighAntimicrobial susceptibility test cards recalled over false colistin resistance results
FDA (Devices) · 2025-10-08
- SevereVITEK 2 AST Test Kits: Ceftriaxone Concentration Error Risk
FDA (Devices) · 2024-05-01
- HighMedical Device Middleware: MYLA Software Fails to Apply AST Filter Rules
FDA (Devices) · 2023-03-08
Same hazard · substrate defect
See all →- HighCochlear implant devices recalled for potential internal electronics substrate defect
FDA (Devices) · 2024-07-24
- HighVIDAS Measles IgG Test Kit Recalled Due to Substrate Error
FDA (Devices) · 2022-01-05
- HighVIDAS Clostridium Difficile GDH test substrate error causes test failure
FDA (Devices) · 2022-01-05
- HighVIDAS Estradiol II Test Device Recalled Due to Substrate Error
FDA (Devices) · 2022-01-05
- ModerateVIDAS RUB IgG Diagnostic Test Kit Recalled for Substrate Defect
FDA (Devices) · 2022-01-05